-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721.P1.80 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster I

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Anna Czyz, MD, PhD1*, Diana Jedrzejuk, MD, PhD2*, Paula Jablonowska2*, Maciej Majcherek2*, Agnieszka Szeremet2*, Bartlomiej Kuszczak2*, Magdalena Karasek2*, Marta Sobas, MD, PhD2* and Tomasz Wrobel, MD, PhD2*

1Wroclaw Medical University, Wroclaw, Poland, Poland
2Wroclaw Medical University, Wroclaw, Poland

Yoshimitsu Shimomura1,2*, Sho Komukai3*, Tetsuhisa Kitamura1*, Tomotaka Sobue1*, Satoshi Yamasaki, MD4, Tadakazu Kondo, MD2, Shohei Mizuno, MD, PhD5*, Kaito Harada, MD, PhD6*, Noriko Doki, MD, PhD7, Masatsugu Tanaka, M.D., Ph.D.8*, Ayumu Ito, MD, PhD9*, Tetsuya Nishida, MD, PhD10*, Hiroyuki Ohigashi, MD, PhD11*, Naoyuki Uchida, MD, PhD12, Ken-ichi Matsuoka, MD, PhD13*, Yoshinobu Kanda14*, Makoto Onizuka, MD, PhD15, Toshiro Kawakita, MD, PhD16*, Nobuhiro Hiramoto17*, Masashi Sawa, MD, PhD18*, Kentaro Fukushima, MD, PhD19*, Junya Kanda, MD, PhD20*, Takahiro Fukuda, MD, PhD9*, Yoshiko Atsuta, MD, PhD21,22* and Masamitsu Yanada23*

1Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Suita, Japan
2Department of Hematology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan
3Division of Biomedical Statistics Department of Integrated Medicine, Osaka University, Graduate School of Medicine, Suita, Japan
4Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, OIT, JPN
5Aichi Medical University, Nagakute, AIC, Japan
6Tokai University School of Medicine, Isehara, JPN
7Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
8Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan
9Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
10Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
11Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan
12Department of Hematology, Toranomon Hospital, Tokyo, Japan
13Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
14Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
15Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan
16Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
17Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan
18Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan
19Osaka University Graduate School of Medicine, Suita, Japan
20Department of Hematology / Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan
21Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan
22Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan
23Department of Hematology and Oncology, Nagoya City University East Medical Center, Nagoya, Japan

Tamer Othman, MD1, Paul B. Koller, MD2, Dongyun Yang, PhD3*, Sally Mokhtari, PhD4, Amanda Blackmon, DO, MS2*, Vaibhav Agrawal, M.D.5, Hoda Pourhassan, MD6, Brian J. Ball, MD2, Idoroenyi Amanam, MD7, Shukaib Arslan, MD2*, Salman Otoukesh, MD2, Karamjeet S. Sandhu, MD8, Ibrahim Aldoss, MD2, Haris Ali, MD2, Amandeep Salhotra, MD5, Ahmed Aribi, MD2*, Andrew Artz, MD, MS9, Yazeed Samara, MD2*, Pamela S. Becker, MD, PhD2, Vinod Pullarkat, MD2, Forest Marc Stewart, MD2, Eileen Patricia Smith, MD2, Anthony Stein, MD2, Guido Marcucci, MD2, Stephen J. Forman, MD, FACP10, Ryotaro Nakamura, MD11 and Monzr M. Al Malki, MD5

1City of Hope, San Lorenzo, CA
2Hematology/HCT, City of Hope National Medical Center, Duarte, CA
3Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
4Clinical and Translational Project Development, City of Hope National Medical Center, Duarte
5Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
6Hematology/HCT, City of Hope, Duarte, CA
7City of Hope National Medical Center, Duarte, CA
8City of Hope National Medical Center, La Crescenta, CA
9City of Hope, Duarte, CA
10Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
11Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Comprehensive Cancer Center, Duarte, CA

Nico Gagelmann1*, Gabriela S. Hobbs, MD2, Edoardo Campodonico3*, Polona Novak, MD, PhD4*, Vaneuza Funke, MD5*, Vanderson Rocha, MD, PhD, MS6*, Nelson Hamerschlak, MD, PhD7, Thomas Schroeder8*, Christina Rautenberg9*, Linette Bosques, BS, MPhil10*, Raffaella Greco11*, Artur Schneider12*, Grzegorz Helbig13* and Nicolaus Kroeger, MD1

1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
3Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Milano, Italy
4university of Ljubljana, Ljubljana, SVN
5HC - UFPR, Curitiba, BRA
6Instituto do Câncer do Estado de São Paulo, University of São Paulo, São Paulo, Brazil
7Albert Einstein Israelite Hospital, Sao Paulo, Brazil
8University Hospital Essen, Essen, AL, DEU
9Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
10Harvard, New Haven, CT
11Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. Ospedale San Raffaele, Milan, Italy
12University Essen, Essen, Germany
13Faculty of Medicine, Medical University of Silesia in Katowice, Katowice, Poland

Michelle L Schoettler, MD1*, Benjamin Watkins, MD2, Muna Qayed, MD1, Satheesh Chonat, MD3, Adrianna Westbrook4* and Kirsten M Williams5

1Emory University, Atlanta, GA
2Emory University, Children’s Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Atlanta, GA
3Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA
4Emory University Biostatistics, Atlanta, GA
5Aflac Cancer and Blood Disorders Center/Emory University, Atlanta, GA

Song Wang1*, Yan Zhu1*, Xiaolu Zhu, MD2*, Haixia Fu, MD3*, Yun He3*, Fengrong Wang, MD4*, Yuanyuan Zhang, MD5*, Xiaodong Mo, MD5*, Chenhua Yan, MD6*, Yuhong Chen5*, Xiangyu Zhao, M.D, Ph.D3, Yingjun Chang, PhD3*, Lanping Xu, MD7*, Kaiyan Liu, MD, PhD8, Xiaojun Huang9* and Xiaohui Zhang, MD, PhD3*

1Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China, Beijing, China
2Peking University Institute of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
3Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
4Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, CHN
5Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
6Peking University People's Hosital, Beijing, China
7Peking University People's Hospital, Beijing, China
8Peking University People’s Hospital, Beijing, China, Beijing, CHN
9Peking University Institute of Hematology, Beijing, CHN

Xingyu Cao1,2*, Jianping Zhang1,2*, Yue Lu, PhD1,2*, Yanli Zhao1,2*, Deyan Liu1,2*, Min Xiong1,2*, Zhijie Wei1,2*, Jiarui Zhou1,2*, Xian Zhang, MD2,3*, Junfang Yang1,2*, Hongxing Liu, MD4,5,6 and Peihua Lu, MD2,3,7*

1Hebei Yanda Lu Daopei Hospital, Langfang, China
2Beijing Lu Daopei Hospital, Beijing, China
3Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang, China
4Division of Pathology & Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China
5Pathology & Laboratory Medicine Division, Hebei Yanda Lu Daopei Hospital, Langfang, Hebei, China
6Pathology & Laboratory Medicine Division, Beijing Lu Daopei Institute of Hematology, Beijing, China
7Beijing Lu Daopei Institute of Hematology, Langfang, China

Radwan Massoud, BS, MD1*, Evgeny Klyuchnikov2*, Ameya Shrinivas Kunte, MD3, Christian Niederwieser, MD4*, Dietlinde Janson3*, Christine Wolschke4*, Francis A. Ayuk, MD5* and Nicolaus Kröger, MD6*

1Department of Stem Cell Transplantation, University Medical Center Hamburg Eppendorf, Hamburg, Germany
2Department of Stem Cell Transplantation,, University Medical Center Hamburg Eppendorf, Hamburg, DEU
3Department of Stem Cell Transplantation, University Medical Center Hamburg Eppendorf, Hamburg, DEU
4Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
5Department of Stem Cell Transplantation with Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
6Department of Stem Cell Transplantation with Research Department Cell and Gene Therapy University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Hiroya Ichikawa1*, Kimikazu Yakushijin, MD, PhD2, Takahiro Tsuji2*, Naoko Takemoto2*, Miki Joyce2*, Yuri Okazoe2*, Ruri Takahashi2*, Sakuya Matsumoto2*, Rina Sakai2*, Keiji Kurata2*, Akihito Kitao2*, Yoshiharu Miyata2*, Yasuyuki Saito, MD, DPhil3*, Shinichiro Kawamoto, MD, PhD2, Katsuya Yamamoto2*, Mitsuhiro Ito, MD, PhD2, Tohru Murayama, MD4*, Hiroshi Matsuoka, MD5* and Hironobu Minami, MD2*

1Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe City, Japan
2Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan
3Division of Molecular and Cellular Signaling, Kobe University Graduate School of Medicine, Kobe, HYO, Japan
4Dept. Hematology, Hyogo Cancer Center, Akashi, Japan
5Division of Bioresource Research and Development, Kobe University Hospital, Kobe, Japan

John A. Cliburn, BA1*, Kara Kubli, PharmD2*, Tate Feeney, PharmD3*, Margaret Blaney2*, Victoria Zhang2*, Omar Aljitawi, MD4, Jane L. Liesveld, MD5, Michael W. Becker, MD6 and Eric J Huselton, MD7*

1School of Medicine, University of Rochester, Rochester, NY
2University of Rochester, Rochester, NY
3University of Michigan, Ann Arbor, MI
4University of Rochester Med. Center, Rochester, NY
5James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
6Univ. of Rochester Medical Center, Rochester, NY
7University of Rochester, Rochester

Stuart Seropian, MD1, James M. Foran, MD2, Boglarka Gyurkocza, MD3, Rajneesh Nath4*, Hannah Choe, MD5, Mark R. Litzow, MD6, Nebu Koshy, MD7*, Patrick J. Stiff, MD8, Ben K. Tomlinson, MD9, Sunil Abhyankar, MD10, Sameem Abedin, MD11, George Chen, MD12,13, Zaid Al-Kadhimi, MD14,15*, Partow Kebriaei, MD16, Mitchell Sabloff, MSc, MD, FRCPC17, Johnnie J. Orozco, MD, PhD18, Katarzyna Joanna Jamieson, MD19*, Margarida Magalhaes-Silverman, MD20, Koen Van Besien, MD, PhD21,22, Michael W. Schuster, MD23, Arjun D. Law, MD24*, Sebastian A. Mayer, MD25, Hillard M. Lazarus, MD26, Jennifer Spross27*, Kate L Li, PhD27*, Elaina Haeuber, MS27*, Madhuri Vusirikala28*, Akash Nahar, MD, MPH27*, Brenda M. Sandmaier, MD29, John Pagel, MD, PhD30, Sergio A. Giralt, MD, FACP31, Avinash Desai, M.D27* and Camille N. Abboud, MD32

1Yale Univ. School of Med., New Haven, CT
2Hematology/Oncology, Mayo Clinic, Jacksonville, FL
3Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Banner MD Anderson Cancer Center, Scottsdale, AZ
5The James Cancer Hospital Solove Research Institute and The Ohio State University Wexner Medical Center, Columbus, OH
6Division of Hematology, Mayo Clinic, Rochester, MN
7Texas Oncology Baylor Charles A. Sammons Cancer Center, Dallas, TX
8Division of Hematology and Oncology, Loyola University Medical Center, Maywood, IL
9University Hospitals Seidman Cancer Center, Cleveland, OH
10University of Kansas Medical Center, Westwood, KS
11Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
12MD Anderson Cancer Center, Houston, TX
13Roswell Park Comprehensive Cancer Center, Buffalo, NY
14University of Alabama at Birmingham, Birmingham, AL
15University of Nebraska Medical Center, Omaha, NE
16Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
17Ottawa Hospital, Ottawa, ON, CAN
18Translational Science and Therapeutics Division, Fred Hutch Cancer Research Center, Seattle, WA
19University of North Carolina, Chapel Hill, NC
20Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa City, IA
21Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY
22Weill Cornell Medical College, New York, NY
23Stony Brook University Cancer Center, Stony Brook, NY
24Hans Messner Allogenic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
25Weill Cornell Medical Center, New York, NY
26Case Western Reserve University, Cleveland, OH
27Actinium Pharmaceuticals, New York, NY
28Actinium Pharmaceuticals, New York
29Fred Hutchinson Cancer Center, Clinical Research Division; University of Washington School of Medicine, Seattle, WA
30Loxo Oncology at Lilly, Stamford, CT
31Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY
32Washington University School of Medicine, Saint Louis, MO

Wenbin Liu, PhD, MD1,2*, Zhengwei Tan Sr.3*, Yuechao Zhao4*, Huijin Hu4*, Dijiong Wu, MD, PhD5 and Baodong Ye, PhD, MD5*

1hematology department, The First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, Zhejiang, China
2The First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, AL, China
3The First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, China
4Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China
5Hematology department, The First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, Zhejiang, China

Heeje Kim, MD, PhD1,2, Byung-Sik Cho1*, Silvia Park2*, Daehun Kwag1,3*, Gi-June Min1*, Jung Yeon Lee4*, Sung-Soo Park1*, Jae-Ho Yoon, MD1, Sung-Eun Lee, MD5*, Ki-Seong Eom1*, Yoo-Jin Kim1, Seok Lee1, Chang-Ki Min1*, Seok-Goo Cho1,6* and Jong-Wook Lee, MD1,7

1Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
4Department of Hematology, Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, Seoul, Korea, Republic of (South)
5Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Houston, TX
6Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University, Seoul, Korea, Republic of (South)
7Department of Hematology, Seoul St. Mary's Hospital Catholic University of Korea, Seoul, Korea, Republic of (South)

Amandeep Salhotra, MD1, Monzr M. Al Malki, MD1, Dongyun Yang, PhD2*, Sally Mokhtari, PhD3, Ahmed Aribi, MD4*, Ibrahim Aldoss, MD4, Vinod Pullarkat, MD4, Ricardo Spielberger, MD4, Pamela S. Becker, MD, PhD4, Karamjeet S. Sandhu, MD4, Haris Ali, MD4, Amanda Blackmon, DO, MS4*, Brian J. Ball, MD4, Paul B. Koller, MD4, Salman Otoukesh, MD4, Shukaib Arslan, MD4, Vaibhav Agrawal, M.D.4, Firoozeh Sahebi, MD4*, Susanta Hui, PhD5*, Guido Marcucci, MD4, Ryotaro Nakamura, MD6, Jeffrey Wong, MD5* and Anthony Stein, MD4

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
3Clinical and Translational Project Development, City of Hope National Medical Center, Duarte
4Hematology/HCT, City of Hope National Medical Center, Duarte, CA
5Radiation Oncology, City of Hope National Medical Center, Duarte, CA
6Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Comprehensive Cancer Center, Duarte, CA

Jieru Wang*, Sisi Zhen*, Erlie Jiang, PhD and Sizhou Feng*

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

David Taylor, MD, MPH1*, Shawn Lim, BS2*, Caitlin Moore, BSN, RN3*, Shereene King, ABA3*, Hilary Haines, MD1*, Sheetal Phadnis, MD4*, Frederick Goldman, MD1*, Joseph Chewning, MD1 and Aman Wadhwa, MD1,2

1Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL
2Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
3Children's of Alabama, Birmingham, AL
4University of Alabama at Birmingham, Birmingham, AL

Israel J. Henig, MD1*, Ohad Geller2*, Dana Yehudai-Ofir1,2*, Baher Krayem, MD1*, Avraham Frisch, MD3*, Hazim Khatib1* and Tsila Zuckerman, MD1,2

1Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
2The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
3Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Rappaport Faculty of Medicine - Technion, Haifa, Israel

Dalila Cysne, MD1*, Wellington F Silva, MD PhD2, Mariana Nassif Kerbauy, MD3*, Iago Colturato, MD4*, Ana Maia, MD5*, Luciana Tucunduva, MD6*, George Barros, MD, MSc7*, Vergilio Colturato, MD8*, Nelson Hamerschlak, MD, PhD9 and Vanderson Rocha, MD, PhD, MS10*

1Hematology, Universidade de Sao Paulo, Hospital das Clínicas da Faculdade de Medicina, Sao Paulo, BRA
2Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina, University of São Paulo (FMUSP), São Paulo, Brazil
3Hematology, Hospital Israelita Albert Einstein, São Paulo, BRA
4Hospital Amaral Carvalho, Jaú, BRA
5Hematology, University of Sao Paulo, Institute of Cancer of Sao Paulo, Sao Paulo, Brazil
6Hospital Sirio Libanes, Sao Paulo, BRA
7Hematology, Hospital de Amor, Barretos, SP, BRA
8Hospital Amaral Carvalho, Jau, SP, BRA
9Albert Einstein Israelite Hospital, Sao Paulo, Brazil
10Service of Hematology, Transfusion and Cell Therapy, and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Clínicas, Faculty of Medicine, São Paulo University, São Paulo, Brazil., São Paulo, Brazil

Shuran Wang*, Peifang Xiao*, Jie Li*, Jun Lu*, Yixin Hu*, Shaoyan Hu, MD, PhD and Jing Ling, PhD*

Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China

Anja Troeger, MD1, Katharina Kleinschmidt, MD2*, Tarek Hanafee-Alali2*, Andreas-Michael Brosig, MD2*, Marcus Jakob, MD2*, Sonja Kramer, MD2*, Robert Offner, MD2*, Daniel Wolff2*, Juergen Foell, MD2* and Selim Corbacioglu, MD, PhD3*

1University Hospital Regensburg, Regensburg, Bavaria, Germany
2University Hospital Regensburg, Regensburg, Germany
3University of Regensburg, Regensburg, Germany

Tatsuya Konishi, MD1*, Kensuke Matsuda, MD, PhD2*, Hidehiro Itonaga, MD, PhD3, Noriko Doki, MD, PhD4, Tetsuya Nishida, MD, PhD5*, Ken-Ichi Matsuoka, MD, PhD6*, Takashi Ikeda, MD, PhD7*, Yoshinobu Kanda8*, Takahiro Fukuda, MD, PhD9*, Junya Kanda, MD, PhD10*, Hirohisa Nakamae, MD, PhD11*, Tatsuo Ichinohe, M.D.Ph.D.12, Yoshiko Atsuta, MD, PhD13* and Ken Ishiyama, MD, PhD14

1Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Japan
2Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
3Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan
4Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
5Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
6Department of Hematology and Oncology, Okayama University Hospital, Okayama, Okayama, Japan
7Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan
8Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
9Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
10Department of Hematology, Kyoto University Hospital, Kyoto, Japan
11Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan
12Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
13Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan
14Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan

Marta Peña1*, Annalisa Paviglianiti1*, Maria Jesús Pascual2*, Beatriz Herruzo3*, Carlos Solano, MD, PhD4, Ana Benzaquen, MD5*, Maria Queralt Salas6*, Montserrat Rovira, MD, PhD7*, Agustin Nieto8*, Ignacio Español9*, Adolfo Jesús Sáez Marín, MD10*, Leyre Bento De Miguel11*, Anna Maria Sureda Balari, MD, PhD1 and Alberto Mussetti1*

1Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
2Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain
3Hematology Department, Hospital Regional Universitario de Málaga, Malaga, Spain
4Hematology Department, Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain
5Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain
6Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICHMO, Barcelona, Spain
7Hospital Clínic de Barcelona, Barcelona, Spain
8Department of Hematology, Complexo Hospitalario de Vigo - Hospital Álvaro Cunqueiro, Vigo, Spain
9Hematology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
10University of Complutense, Hospital 12 de Octubre, Madrid, Spain
11Hospital Universitario Son Espases, IdISBa, Palma de Mallorca, Spain

Ramzi Hamouche, MD1, Francine M. Foss, MD2, Sayeef Mirza, MD, MPH3, Mengyang Di, MD, PhD2*, Iris Isufi2, Noffar Bar, MD4, Lohith Gowda, MD5*, Sarah Perreault, PharmD6*, Kenneth Roberts7*, Stuart Seropian, MD8 and Tarsheen Sethi, MD, MBBS, MSc9

1Department of Hematology, Yale Cancer Center, New Haven, CT
2Yale University School of Medicine, New Haven, CT
3Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
4Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, Cheshire, CT
5Yale Cancer Center and Yale School of Medicine, New Haven, CT
6Pharmacy, Yale New Haven Hospital, New Haven, CT
7Department of Radiation Oncology, Yale University, New Haven, CT
8Yale Univ. School of Med., New Haven, CT
9Hematology, Yale University School of Medicine, Guilford, CT

Juan Carlos Olivares-Gazca, MD1,2*, María de Lourdes Pastelín-Martínez, MD3,4*, Merittzel Abigail Montes-Robles, MD3,4*, Moisés Manuel Gallardo-Pérez, MD, MSc2,5*, Edgar Jared Hernández-Flores, MD3,6*, Max Robles-Nasta, MD2,3*, Daniela Sánchez-Bonilla, MD3,6*, César Homero Gutierrez-Aguirre, PhD7*, Andres Gomez-De Leon, MD8, David Gomez-Almaguer, MD9, Guillermo José Ruiz-Delgado, MD2,10 and Guillermo José Ruiz-Arguelles, FRCP2,11

1Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, MEX
2Universidad Popular Autónoma del Estado de Puebla, Puebla, PU, Mexico
3Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, PU, Mexico
4Facultad de Medicina, Universidad Anáhuac Puebla, Puebla, PU, Mexico
5Investigación Clínica, Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, MEX
6Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, PU, Mexico
7Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico
8Servicio de Hematología, Universidad Autónoma de Nuevo León,Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”,, Monterrey, Nuevo Leon, Mexico
9Servicio de Hematologia, Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, Mexico
10Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, Mexico
11Centro De Hematologia Medicina Interna, Puebla, Pue, Mexico

Kittika Poonsombudlert, MD1, Sarah L Mott, MS1*, Brenda Miller, RN1*, Hira Shaikh, MBBS2*, Christopher Strouse, MD2, Jonathan Lochner, PharmD2*, Umar Farooq1 and Margarida Magalhaes-Silverman, MD1

1Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa City, IA
2Division of Hematology, Oncology and Blood & Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA

Tomoyasu Jo, MD, PhD1*, Tomoaki Ueda, MD, PhD2*, Yu Akahoshi, MD, PhD3*, Tadakazu Kondo, MD4, Naoyuki Uchida, MD, PhD5, Masatsugu Tanaka, M.D., Ph.D.6*, Hirohisa Nakamae, MD, PhD7*, Noriko Doki, MD, PhD8, Shuichi Ota, MD9, Masashi Sawa, MD, PhD10*, Hiroyuki Ohigashi11*, Yumiko Maruyama, MD, PhD12*, Nobuyuki Takayama, MD, PhD13, Tetsuya Nishida, MD, PhD14*, Yoshinobu Kanda15*, Tatsuo Ichinohe, MD, PhD16*, Yoshiko Atsuta, MD, PhD17* and Yasuyuki Arai, MD, PhD18

1Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, KYO, Japan
2Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
3Jichi Medical University Saitama Medical Center, Saitama City, JPN
4Department of Hematology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan
5Department of Hematology, Toranomon Hospital, Tokyo, Japan
6Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan
7Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan
8Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
9Sapporo Hokuyu Hospital, Sapporo, JPN
10Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan
11Department of Hematology, Hokkaido University Hospital, Sapporo, Japan
12Department of Hematology, University of Tsukuba Hospital, Tsukuba, JPN
13Department of Hematology, Kyorin University Faculty of Medicine, Mitaka, Japan
14Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
15Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
16Department of Hematology and Oncology, Research Institute For Radiation Biology and Medicine, Hiroshima University, Hiroshima, JPN
17Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan
18Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto City, JPN

*signifies non-member of ASH